NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
49 hedge funds and large institutions have $1.43M invested in Navidea Biopharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
49
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$36.8K | |
| 2 | +$21K | |
| 3 | +$17K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$14.4K |
| 5 |
VF
Virtu Financial
New York
|
+$12.6K |
Top Sellers
| 1 | -$7K | |
| 2 | -$5K | |
| 3 | -$5K | |
| 4 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
-$4K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$4K |